MoneyWorks4Me

Sakar Healthcare - Quaterly Results

06 Nov 2023 Evaluate
The September 2023 quarter revenue stood at Rs. 340.79 millions, up 10.97% as compared to Rs. 307.09 millions during the corresponding quarter last year.Net profit for the quarter ended September 2023 increased significantly by 86.99% to Rs. 36.35 millions from Rs. 19.44 millions.Operating profit for the quarter ended September 2023 rose to 100.17 millions as compared to 91.96 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 340.79 307.09 10.97 730.68 592.43 23.34 1333.59 1282.27 4.00
Other Income 6.58 5.95 10.59 21.79 10.03 117.25 46.75 21.71 115.34
PBIDT 100.17 91.96 8.93 205.65 175.61 17.11 378.16 315.73 19.77
Interest 16.45 9.93 65.66 37.22 18.52 100.97 59.50 28.97 105.38
PBDT 83.72 82.03 2.06 168.43 157.09 7.22 318.61 286.76 11.11
Depreciation 42.22 37.66 12.11 87.41 73.35 19.17 149.86 96.67 55.02
PBT 41.50 44.37 -6.47 81.02 83.74 -3.25 168.75 190.09 -11.23
TAX 5.15 24.93 -79.34 16.25 35.52 -54.25 41.18 37.65 9.38
Deferred Tax 5.15 24.93 -79.34 16.25 35.52 -54.25 41.18 3.55 1060.00
PAT 36.35 19.44 86.99 64.77 48.22 34.32 127.57 152.44 -16.31
Equity 213.50 186.18 14.67 213.50 186.18 14.67 190.40 171.18 11.23
PBIDTM(%) 29.39 29.95 -1.84 28.15 29.64 -5.05 28.36 24.62 15.16
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..